financetom
Business
financetom
/
Business
/
Bombardier CEO Alain Bellemare to step down, to be replaced by Eric Martel
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Bombardier CEO Alain Bellemare to step down, to be replaced by Eric Martel
Mar 12, 2020 2:40 AM

Canada's Bombardier Inc said late Wednesday Chief Executive Officer Alain Bellemare would step down and be replaced by former company executive and Hydro-Quebec CEO Eric Martel.

Bellemare, who took over the top job at Bombardier in 2015, has steered the company through some of its biggest challenges, including a brush with bankruptcy due to its costly C Series jet program.

Under his watch, the company has narrowed its focus on making business jets, after offloading its stake in the A220 passenger jet program - formerly known as the C Series - to Airbus SE and selling the rail division to France's Alstom SA earlier this year.

"With the five-year turnaround plan nearing completion, the board, including Mr. Bellemare, unanimously concluded that it was the appropriate time for a new leader to take the helm of the corporation," Bombardier said in a statement.

Martel had worked with Bombardier for 13 years and was the president of its business aircraft unit before joining the hydropower producer as CEO in 2015.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Takeda Pharmaceutical Receives FDA Approval to Expand Iclusig's Indication in Blood Cancer Sub-Type
Takeda Pharmaceutical Receives FDA Approval to Expand Iclusig's Indication in Blood Cancer Sub-Type
Mar 19, 2024
01:00 PM EDT, 03/19/2024 (MT Newswires) -- Takeda Pharmaceutical ( TAK ) on Tuesday said it received the US Food and Drug Administration's approval to expand the indication of Iclusig to include the treatment of adult patients who are newly diagnosed with a sub type of blood cancer called Philadelphia chromosome-positive acute lymphoblastic leukemia. The company's supplemental new drug application...
--Nvidia Poised to Grab Larger Chunk of Annual Data Center Spending, CEO Huang Reportedly Says
--Nvidia Poised to Grab Larger Chunk of Annual Data Center Spending, CEO Huang Reportedly Says
Mar 19, 2024
01:05 PM EDT, 03/19/2024 (MT Newswires) -- Price: 892.45, Change: +7.90, Percent Change: +0.89 ...
Cox, music labels lose bid for new appeal in billion-dollar copyright case
Cox, music labels lose bid for new appeal in billion-dollar copyright case
Mar 19, 2024
* 4th Circuit had tossed verdict for record labels over Cox user infringement * Appeals court rejects rehearing requests from both Cox and labels By Blake Brittain March 19 (Reuters) - Cox Communications and a group of major record labels, including Universal Music Group , Warner Music Group ( WMG ) and Sony Music, failed to convince a U.S. appeals...
DelphX Capital Markets Teams Up With Castle Placement to Expand Reach of Credit Rating Security Product; Up Nearly 11%
DelphX Capital Markets Teams Up With Castle Placement to Expand Reach of Credit Rating Security Product; Up Nearly 11%
Mar 19, 2024
01:05 PM EDT, 03/19/2024 (MT Newswires) -- DelphX Capital Markets Inc. ( DPXCF ) on Tuesday surged 10.7% on last look after reporting that it has teamed up with Castle Placement LLC to accelerate the market exposure and use of the DelphX Credit Rating Security product, effective March 16. Castle will provide services to support the launch of the CRS...
Copyright 2023-2026 - www.financetom.com All Rights Reserved